Clinical Trials Logo

Clinical Trial Summary

The finding that the combination of the inactivated probiotic Bifidobacterium Lactis (BPL1), inulin as a source of soluble fiber and omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), in a surimi matrix has positive effects on visceral adiposity , insulin resistance and plasma tryclycerides in a preclinical model of rats that present obesity induced by diet is the basis of the present hypothesis. This finding is based on the fact that these three bioactive compounds exert these effects through sensibly different and complementary mechanisms, which suggests that their combined use may have synergistic effects. On this basis the present hypothesis is posed: the consumption of surimi enriched with inactivated probiotic BPL1, inulin and omega-3 fatty acids, in the same doses that have been effective in obese rats (SIAP), can induce a reduction of more than 5% of visceral adipose tissue, being clinically relevant in people with abdominal obesity. If the effect on abdominal obesity is associated or not with a lower glycemia and / or absorption of fats induced by the consumption of surimi can be evaluated by monitoring these parameters for 4 hours after the ingestion of a breakfast high in fat. The main objective of this study was to evaluate the effects of the consumption of surimi enriched with the probiotic BPL1, inulin and omega-3 fatty acids, on visceral abdominal adiposity in people with abdominal obesity.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03630588
Study type Interventional
Source Technological Centre of Nutrition and Health, Spain
Contact
Status Completed
Phase Phase 2
Start date August 2, 2018
Completion date December 23, 2018

See also
  Status Clinical Trial Phase
Completed NCT04105075 - COPD in Obese Patients
Recruiting NCT04877548 - Powdered Fermented Fruits for Glycemia Reduction N/A
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Active, not recruiting NCT02558920 - Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
Recruiting NCT04043520 - Bioenergetic Effects of Aging and Menopause (BEAM) Phase 4
Completed NCT02217423 - Abdominal Circumference and Cardiorespiratory Repercussions in Patients Submitted to Physical Therapy N/A
Completed NCT06290674 - Extracorporeal Shockwave on Abdominal Adiposity and Lipid Profile N/A
Not yet recruiting NCT05004558 - Effects of Remote-based Resistance Training on Cardiometabolic Risk Factors, Cognitive Function, and Quality of Life in Adults Living With Alzheimer's Disease and/or Related Dementias N/A
Completed NCT04621032 - Obstructive Sleep Apnea Destabilizes Myocardial Repolarization Homogeneity
Completed NCT03347604 - Effect of Body Position on Spirometry in Abdominal Obesity.
Completed NCT02654535 - Meta-analyses of Nuts and Risk of Obesity
Completed NCT03805516 - Central Obesity and Cancer Prevention for Chinese American Women N/A
Completed NCT03523403 - Obesity-related Health Benefits of Apples N/A
Terminated NCT03700827 - Effects of Aerobic and Resistance Training on Abdominal Fat Loss N/A
Terminated NCT03138369 - Vestibular Stimulation to Trigger Adipose Loss Clinical Trial
Completed NCT01716819 - Role of the Renin Angiotensin Aldosterone System in the Mechanisms of Transition to Heart Failure in Abdominal Obesity N/A
Completed NCT05612282 - The Impact of the Distribution of Adipose Tissue on the Occurrence of Metabolic Disorders and the Level of Cardiopulmonary Fitness
Terminated NCT03115385 - Probiotics and the Gut Microbiome in Obese Hispanic Youth N/A
Completed NCT04911582 - Does the Bioactive Substance in Coffee, Cafestol, Have Preventive Properties on Type-2-diabetes? (Acute Substudy) N/A
Completed NCT04754464 - Clinical Study on the Effect of a Synbiotic on Body Fat Mass N/A